Latest Breaking News On - Heron therapeutics - Page 4 : comparemela.com

Ionis, Biogen Down on Ending Development of ALS Drug - Heron Therapeutics (NASDAQ:HRTX), Biogen (NASDAQ:BIIB)

Ionis, Biogen Down on Ending Development of ALS Drug - Heron Therapeutics (NASDAQ:HRTX), Biogen (NASDAQ:BIIB)
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Heron therapeuticsEarnings of ligand pharmaceuticalsLigand pharmaceuticalsBiogen incAngelman syndrome foundationIonis pharmaceuticals incIonis pharmaceuticalsAngelman syndromeZacks rankLigand pharmaceuticalHeron therapeutic

Heron Therapeutics (NASDAQ:HRTX) Receives Buy Rating from Needham & Company LLC

Heron Therapeutics (NASDAQ:HRTX – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at Needham & Company LLC in a report issued on Thursday, Benzinga reports. They presently have a $5.00 price objective on the biotechnology company’s stock. Needham & Company LLC’s price target would suggest a potential upside of 66.67% from the […]

Jw asset managementTejara capital ltdOrchard capital managementHeron therapeutics incNeedham companyHeron therapeuticsGet free reportCapital one financialCapital managementAsset managementCapital ltdHeron therapeutics daily

Heron Therapeutics, Inc (NASDAQ:HRTX) Expected to Earn Q2 2024 Earnings of ($0 04) Per Share

Heron Therapeutics, Inc (NASDAQ:HRTX) Expected to Earn Q2 2024 Earnings of ($0 04) Per Share
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesNorthland capmkSusquehanna fundamental investmentsCommonwealth equity servicesHeron therapeutics incNeedham companyBoard of administration florida retirement systemHeadlands technologiesVictory capital management incHeron therapeuticsFree reportHeron therapeuticGet free reportOne financialTherapeutics trading downCapital management

Heron Therapeutics, Inc (NASDAQ:HRTX) Q1 2024 Earnings Call Transcript

Heron Therapeutics, Inc (NASDAQ:HRTX) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

South carolinaUnited statesNorth carolinaTim chiangIra duarteCarl byrnesKevin warnerSerge berlangerWilliam forbesMelissa dorelUnidentified company representativeCapital oneHeron therapeutics incDevelopment officerHeron therapeuticsCall transcript may

Heron Therapeutics: Q1 Earnings Snapshot

Heron Therapeutics: Q1 Earnings Snapshot
smdailyjournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from smdailyjournal.com Daily Mail and Mail on Sunday newspapers.

Zacks investment researchHeron therapeutics incHeron therapeuticsSan diego basedWall street